Brief: Avid Bioservices Reports Financial Results For First Quarter Ended July 31, 2022
Sept 6 (Reuters) - Avid Bioservices Inc CDMO.O :
* AVID BIOSERVICES INC Q1 REVENUE ROSE 19 PERCENT TO $36.7
MILLION
* AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR FIRST
QUARTER
ENDED JULY 31, 2022 AND RECENT DEVELOPMENTS
* AVID BIOSERVICES INC Q1 EARNINGS PER SHARE $0.02
* AVID BIOSERVICES INC- IS REITERATING FULL YEAR REVENUE
GUIDANCE
FOR FISCAL 2023 OF $140 MILLION TO $145 MILLION
Source text for Eikon: ID:nGNX8mHR34
Further company coverage: CDMO.O
Recent news on Avid Bioservices
See all newsBrief: Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction
Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce
Press Digest: Wall Street Journal - Nov. 7
Brief: Avid Bioservices to be acquired for $1.1 bln by GHO Capital Partners, Ampersand Capital Partners